Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:VSEE 21 October 2025 - 4 November 2025

Telehealth Trailblazer VSee Health (VSEE) Skyrockets on Game-Changing Deals & Federal Green Light

Telehealth Trailblazer VSee Health (VSEE) Skyrockets on Game-Changing Deals & Federal Green Light

VSee Health secured a three-year contract to deploy virtual urgent care at over 100 facilities for a major U.S. academic health system, starting January 2026. On Oct. 28, 2025, its telehealth platform received FedRAMP High Authorization, enabling federal agency use. Shares surged from $0.45 to over $1.00 after the news. Q2 2025 revenue nearly doubled to $3.4 million, but the company remains unprofitable.
4 November 2025
·
VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health shares jumped 94% to $0.945 on Oct. 21 after announcing a multi-year teleradiology contract with a major Level-1 trauma hospital system, expected to generate $10 million over two years. Q2 2025 revenue nearly doubled year-over-year to $3.4 million, driven by the iDoc Telehealth acquisition. Analyst ratings remain bullish, with targets as high as $5. Volatility persists as VSEE trades below $1.
22 October 2025
·
VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee Health shares jumped 75% on Oct. 21 after announcing a multi-year teleradiology contract worth over $10 million with a leading Level 1 trauma hospital system. Trading volume surged to 226 million shares. The deal is expected to double VSee’s annual recurring revenue, with potential for an additional $5 million if targets are met. VSee recently secured a Nasdaq extension to resolve late filings.
21 October 2025

Stock Market Today

  • Centene Launches Community Programs Amid Depressed Stock Price: What Investors Should Know
    March 20, 2026, 6:30 AM EDT. Centene Corp subsidiaries have initiated community-focused programs targeting behavioral health, job training, housing support, and diabetes care, aiming to assist underserved populations across major U.S. markets. These efforts come as Centene shares (NYSE:CNC) remain under pressure, with a recent price of $35.57, down 13.7% in the past month and 40.3% over one year. Investors should monitor these initiatives closely for insights into Centene's regulatory relations and potential impact on medical loss ratios and membership retention. Despite current headwinds, the stock trades nearly 17% below analyst targets and is marked as undervalued by Simply Wall St. Key risks include rising costs without clear reimbursement or measurable health outcomes.
Go toTop